Cargando…
Indications for and transitioning to secondary treatment while on active surveillance for prostate cancer
For men with lower risk prostate cancer, there is ever-growing literature that demonstrates the oncologic safety of deferring radical treatment and opting for regular monitoring for disease progression. This strategy’s success is largely owed to appropriate, systematic monitoring protocols that typi...
Autores principales: | Glass, Allison S., Dall’Era, Marc A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911543/ https://www.ncbi.nlm.nih.gov/pubmed/29732282 http://dx.doi.org/10.21037/tau.2018.02.08 |
Ejemplares similares
-
Active Surveillance for Intermediate Risk Prostate Cancer
por: Dall'Era, Marc A., et al.
Publicado: (2016) -
Active surveillance for prostate cancer
por: Dall’Era, Marc A., et al.
Publicado: (2018) -
Active Surveillance for Localized Prostate Cancer – Current Practices and Recommendations
por: Wu, Jennifer N., et al.
Publicado: (2010) -
Defining the Optimal Management Strategy for Small Renal Masses
por: Dall’Era, Marc, et al.
Publicado: (2021) -
Differential expression of CD10 in prostate cancer and its clinical implication
por: Dall'Era, Marc A, et al.
Publicado: (2007)